Literature DB >> 16369971

Non-Hodgkin disease in beta-thalassemia major.

Zaher K Otrock1, Ali I Shamseddine, Ali T Taher.   

Abstract

Thalassemia is a spectrum of diseases characterized by the decrease or absence of globin chains. The occurrence of lymphoma in thalassemia has rarely been reported, and our review of the English literature revealed only four cases. Because anemia is always masked by regular transfusions in thalassemic patients, physicians discover a hidden malignancy late in the course of the disease. We hereby report the case of a thalassemic patient developing non-Hodgkin disease and discuss the possibility of a link between the two disease entities. This case is intended to alert physicians of the possibility of a malignancy in thalassemia patients. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16369971     DOI: 10.1002/ajh.20463

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  4 in total

1.  A strategy for the clinical remission of acute lymphoblastic leukemia elicited by treatment of β-thalassemia major: A case report.

Authors:  Miguel A Palomo-Colli; Marta Zapata-Tarres; Osvaldo D Castelán-Martínez; Luis E Juárez-Villegas; Lourdes P Córdova-Hurtado
Journal:  Mol Clin Oncol       Date:  2017-12-08

2.  Frequency of thyroid nodules in patients with β-thalassemias in Southern Iran.

Authors:  S Haghpanah; P Pishdad; T Zarei; A Shahsavani; F Amirmoezi; H Ilkhanipoor; H Ilkhanipoor; S Safaei; F Setoodegan; V De Sanctis; M Karimi
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Jan-Mar       Impact factor: 0.877

3.  Hematological malignancies complicating β-thalassemia syndromes: a single center experience.

Authors:  Samin Alavi; Alieh Safari; Elham Sadeghi; Somayeh Amiri
Journal:  Blood Res       Date:  2013-06-25

4.  Thalassemia Intermedia and Acute Lymphoblastic Leukemia: Is it a Coincidental Double Diagnosis?

Authors:  Deniz Tuğcu; Zeynep Karakaş; Müge Gökçe; Leyla Ağaoğlu; Ayşegül Unüvar; Ebru Sarıbeyoğlu; Arzu Akçay; Omer Devecioğlu
Journal:  Turk J Haematol       Date:  2014-09-05       Impact factor: 1.831

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.